Tempest Therapeutics is a San Francisco-based biopharmaceutical company that specializes in developing innovative targeted and immune-mediated cancer therapies. Their pipeline consists of first-in-class small molecule product candidates with the potential to benefit a wide range of patients.
With a focus on modulating validated and new pathways, Tempest Therapeutics aims to develop novel therapeutics that can effectively combat cancer. They have been actively involved in scientific research and have made significant progress in their mission to provide cutting-edge treatments for cancer patients.
Generated from the website